Fact CheckerSign in

NCT07281794Recruiting

Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 12 Feb 2026

Brief summary (registry, in English)

This observational study aims to explore the use of the DANU Smart Socks for gait and balance assessment in people with Parkinson's (PwP). The study will compare walking and balance outcomes produced by DANU from people with Parkinson's (PwP) and a group of healthy individuals of similar age. The project aims to investigate if the gait and balance data collected are linked to measures of Parkinson's symptoms such as disease progression and cognitive abilities. Gait and balance outcomes will be obtained through one observational laboratory visit.

Status (registry)
Recruiting
Study type
Observational
Enrollment
60 (estimated)
First submitted
16 Sept 2025
Start date
8 Aug 2025
Primary completion date
Sept 2027
Lead sponsor
Northumbria University
NCT number
NCT07281794

What you commit to

  • Study type: Observational
  • Planned participants: 60
  • From 8 Aug 2025 to the primary completion date, Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Parkinson's Group Inclusion Criteria:- Clinical diagnosis of Parkinson's by a movement disorder specialist according to UK brain bank criteria.
  • PD stages I-III (Hoehn and Yahr Rating Scale)
  • Able to attend Northumbria University, Newcastle Upon Tyne for study visits.
  • Able to walk and stand unassisted for a minimum of 2-minutes.
  • Aged 50 years old or over
    • Parkinson's Group Exclusion Criteria:
  • History of neurological disorders other than PD (e.g., Huntington's disease, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease etc.)
  • Unable to walk or stand unaided.
  • Montreal Cognitive Assessment (MoCA) score \< 21
  • Significant issues unrelated to PD that may affect gait (e.g., musculoskeletal issues, back pain, recent surgery etc.)
    • Healthy Control Inclusion Criteria:
  • Ability to attend Northumbria University, Newcastle Upon Tyne for study visits.
  • Aged 50 years old or over.
  • Able to walk and stand unassisted for a minimum of 2-minutes.
    • Healthy Control Exclusion Criteria:
  • History of neurological disorders (e.g. Huntington's disease, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease etc.)
  • Significant issues that may affect walking (e.g., musculoskeletal issues, back pain, recent surgery etc.)

Age in the registry: 50 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Northumbria University
Coordinator of this site? Confirm its status
Newcastle upon TyneUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.